Chang, S., Lai, Y., Chang, C., Huang, L., Chen, S., Tan, K. T., . . . Lai, J. (2019). Concomitant Genetic Alterations are Associated with Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated with Tyrosine Kinase Inhibitors. Transl Oncol.

Chang, Shih-Chieh, Yi-Chun Lai, Cheng-Yu Chang, Li-Kuo Huang, Shu-Jen Chen, Kien Thiam Tan, Pei-Ning Yu, ja Jiun-I Lai. "Concomitant Genetic Alterations Are Associated With Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated With Tyrosine Kinase Inhibitors." Transl Oncol 2019.

Chang, Shih-Chieh, et al. "Concomitant Genetic Alterations Are Associated With Worse Clinical Outcome in EGFR Mutant NSCLC Patients Treated With Tyrosine Kinase Inhibitors." Transl Oncol 2019.